Mohammad Maqusood Alam, an experienced Medicinal Chemist with an interest in new drug discovery and development research, contributed to medicinal chemistry programs for drug discovery, targeting cancer and infectious diseases, and contributed to rational drug design based on available protein structure and also on an analogue approach. He has experience in the early-stage drug discovery program from Hits-Lead Discoveries, and Lead Optimisation & Preclinical Development, and performed derivative synthesis to improve in vitro potency, SAR/SPR, physicochemical property, and ADMET studies. His skills encompass molecular docking and modeling, as well as in silico optimization of drug molecules, and his specialties include infectious disease (SARS-CoV-2, Influenza, and tuberculosis), oncology/immunology, and neurodegenerative drug discovery programs. His long-term goals include directing a research group in the pharmaceutical and chemical sciences.
Mohammad Maqusood Alam, an experienced Medicinal Chemist with an interest in new drug discovery and development research, contributed to medicinal chemistry programs for drug discovery, targeting cancer and infectious diseases, and contributed to rational drug design based on available protein structure and also on an analogue approach. He has experience in the early-stage drug discovery program from Hits-Lead Discoveries, and Lead Optimisation & Preclinical Development, and performed derivative synthesis to improve in vitro potency, SAR/SPR, physicochemical property, and ADMET studies. His skills encompass molecular docking and modeling, as well as in silico optimization of drug molecules, and his specialties include infectious disease (SARS-CoV-2, Influenza, and tuberculosis), oncology/immunology, and neurodegenerative drug discovery programs. His long-term goals include directing a research group in the pharmaceutical and chemical sciences.